103 related articles for article (PubMed ID: 20037449)
1. [A case of esophageal cancer associated with colon cancer successfully treated with combination chemotherapy of FOLFOX and concurrent radiotherapy].
Watanabe Y; Tsutsui M; Takeda S; Yoshino S; Oka M
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2439-41. PubMed ID: 20037449
[TBL] [Abstract][Full Text] [Related]
2. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
[TBL] [Abstract][Full Text] [Related]
3. [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].
Kubo N; Morimoto J; Tanaka H; Ohira M; Noda E; Amano R; Inoue T; Yamada N; Yashiro M; Maeda K; Yamashita Y; Muguruma K; Sawada T; Hirakawa K
Gan To Kagaku Ryoho; 2009 Nov; 36(12):1997-9. PubMed ID: 20037303
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer.
Conroy T; Viret F; François E; Seitz JF; Boige V; Ducreux M; Ychou M; Metges JP; Giovannini M; Yataghene Y; Peiffert D
Br J Cancer; 2008 Nov; 99(9):1395-401. PubMed ID: 18841161
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
[TBL] [Abstract][Full Text] [Related]
6. [A case of advanced esophageal cancer with multiple lymph node metastases successfully treated with induction chemotherapy consisting of nedaplatin and 5-FU followed by chemoradiotherapy].
Sasaki T; Nakamura K; Toba T; Kimura M; Ohga S; Urashima Y; Terashima H; Masuda K
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1417-20. PubMed ID: 12214470
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.
Shitara K; Munakata M; Muto O; Kasai M; Okada R; Mitobe S; Sakata Y
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1079-84. PubMed ID: 17637544
[TBL] [Abstract][Full Text] [Related]
8. A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer.
Sato Y; Takayama T; Sagawa T; Okamoto T; Miyanishi K; Sato T; Araki H; Iyama S; Abe S; Murase K; Takimoto R; Nagakura H; Hareyama M; Kato J; Niitsu Y
Cancer Chemother Pharmacol; 2006 Nov; 58(5):570-6. PubMed ID: 16463059
[TBL] [Abstract][Full Text] [Related]
9. [A case of esophageal carcinoma with multiple liver metastases successfully treated with nedaplatin (NDP) and 5-fluorouracil (5-FU) combined with radiotherapy].
Kaneko K; Ito H; Ito T; Konishi K; Kurahashi T; Yamamoto T; Eguchi J; Kitahara T; Mitamura K
Gan To Kagaku Ryoho; 2001 Jun; 28(6):831-4. PubMed ID: 11432353
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer.
Oh SY; Kwon HC; Seo BG; Kim SH; Kim JS; Kim HJ
Acta Oncol; 2007; 46(3):336-41. PubMed ID: 17450469
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
12. Biweekly oxaliplatin in combination with continuous infusional 5-fluorouracil and leucovorin (modified FOLFOX-4 regimen) as first-line chemotherapy for elderly patients with advanced gastric cancer.
Liu ZF; Guo QS; Zhang XQ; Yang XG; Guan F; Fu Z; Wang MY
Am J Clin Oncol; 2008 Jun; 31(3):259-63. PubMed ID: 18525305
[TBL] [Abstract][Full Text] [Related]
13. [A case of multiple advanced esophageal carcinomas with abdominal LN metastases showing complete response after chemoradiotherapy with concurrent cisplatin, 5-FU and adriamycin chemotherapy].
Yasuda T; Yano M; Takiguchi S; Kimura Y; Fujiwara Y; Monden M
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1737-40. PubMed ID: 14619507
[TBL] [Abstract][Full Text] [Related]
14. [Chemoradiotherapy using platinum analogs/5-FU for advanced esophageal cancer].
Shibata S; Kawasaki H; Nakai M; Morohashi H; Matsuya H; Yamada K; Morita T; Sasaki M
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2209-12. PubMed ID: 12484039
[TBL] [Abstract][Full Text] [Related]
15. [A case report of esophageal small cell carcinoma responding well to chemotherapy of 5-FU and cisplatin combined with radiotherapy].
Yoshikawa T; Kato H; Nikkuni K; Sasaki K; Tomidokoro T; Satoh T
Gan To Kagaku Ryoho; 1999 Jul; 26(8):1181-4. PubMed ID: 10431586
[TBL] [Abstract][Full Text] [Related]
16. [A case of local advanced cervical esophageal cancer treated with concurrent radiochemotherapy followed by surgery].
Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Takakita S; Kusumi F; Kato Y; Takeda H
Gan To Kagaku Ryoho; 1997 Oct; 24(13):2001-4. PubMed ID: 9350249
[TBL] [Abstract][Full Text] [Related]
17. A Phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites.
Oh SY; Kwon HC; Lee S; Lee DM; Yoo HS; Kim SH; Jang JS; Kim MC; Jeong JS; Kim HJ
Jpn J Clin Oncol; 2007 Dec; 37(12):930-5. PubMed ID: 18211984
[TBL] [Abstract][Full Text] [Related]
18. [A case of a 14-month survival patient on advanced esophageal cancer with uncontrolled brain metastasis completely responding to nedaplatin, adriamycin, plus 5-FU (NAF) therapy].
Iijima S; Makari Y; Kato T; Ooshima S; Hoshi M; Doi T; Miyake Y; Sakamoto T; Kato A; Miyo M; Kurokawa E; Kikkawa N
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2052-4. PubMed ID: 20037320
[TBL] [Abstract][Full Text] [Related]
19. Oxaliplatin plus high-dose leucovorin and 5-fluorouracil (FOLFOX 4) in platinum-resistant and taxane-pretreated ovarian cancer: a phase II study.
Pectasides D; Pectasides M; Farmakis D; Gaglia A; Koumarianou A; Nikolaou M; Koumpou M; Kountourakis P; Papaxoinis G; Mitrou P; Economopoulos T; Raptis SA
Gynecol Oncol; 2004 Oct; 95(1):165-72. PubMed ID: 15385127
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability and sensitivitiy to FOLFOX treatment in metastatic colorectal cancer.
des Guetz G; Mariani P; Cucherousset J; Benamoun M; Lagorce C; Sastre X; Le Toumelin P; Uzzan B; Perret GY; Morere JF; Breau JL; Fagard R; Schischmanoff PO
Anticancer Res; 2007; 27(4C):2715-9. PubMed ID: 17695437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]